US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 14.950
  • -0.020-0.13%
Close Aug 29 16:00 ET
  • 14.900
  • -0.050-0.33%
Post 20:02 ET
47.39BMarket Cap46.14P/E (TTM)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Takeda Pharmaceutical Q1 2025 Earnings Date

Currency：JPYJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.08T
1.21T
+126.69B
Beat Est.
+2.14%
+14.11%
+11.72%
EPS
--
29.97
--
+4.94%
Analyst Rating
No Data

Takeda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.163T--
Oct 31, 20242025/Q2-- / 1.070T--
Jul 31, 20242025/Q11.208T / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.163T--
Oct 31, 20242025/Q2-- / 1.070T--
Jul 31, 20242025/Q11.208T / 1.081T--
May 9, 20242024/Q41.051T / 899.902B--
Feb 1, 20242024/Q31.111T / 1.001T--

Unlock Free Earnings Estimates

Takeda Pharmaceutical Earnings Reports

  • 6-K: Earnings Report for the Three-month Period Ended June 30, 2024

    Jul 31 06:05 ET

  • 6-K: Corporate Governance Report

    Jul 10 06:09 ET

  • 6-K: 2024 Annual Integrated Report

    Jul 1 06:39 ET

  • 20-F: FY2024 Annual Report

    Jun 26 06:13 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Infectious Disease
    Infectious Disease
    Intraday0.00%